Abstract

A MDH was diagnosed in 48 (2.41%) of the 1989 patients evaluated, being 32 females, with a mean age of 50±14, 43 years. A total of 137 episodes were reported: 80 (58.39%) suggested an IgE-mediated reaction, 37 (27%) a non-immunologic mechanism (cross-reactive to NSAIDs) and 20 (14.55%) a T-cell mediated reaction. The percentage of MHD in patients with IgE-mediated reactions (9.78%) was higher compared to those with T-cell mediated reactions (5.23%) and non-immunologic reactions (1.91%) (p<0,0001). The drugs most frequently involved were dypirone (13.6%), ciprofloxacin (12.1%), amoxicillin-clavulanic acid (11.4%), amoxicillin (10%), ASA (8.6%), ibuprofen (7.1%) and moxifloxacin (5.7%). Sensitivity to 2 chemically unrelated drugs was diagnosed in 44 patients and to 3 drugs in 4. The most frequent clinical entities were anaphylaxis/shock (42.85%) and urticaria (34.92%). Conclusions Patients with IgE-mediated reactions have a higher risk for developing MHD. More studies are needed to confirm this finding.

Highlights

  • Multiple drug hypersensitivity (MDH) has been defined as a hypersensitivity to two or more chemically unrelated drugs

  • Patterns of response and drug involved in patients with multiple drug hypersensitivity syndrome

  • Studies focusing in MDH in large populations are lacking

Read more

Summary

Introduction

Multiple drug hypersensitivity (MDH) has been defined as a hypersensitivity to two or more chemically unrelated drugs. Patterns of response and drug involved in patients with multiple drug hypersensitivity syndrome From 6th Drug Hypersensitivity Meeting (DHM 6) Bern, Switzerland. Background Multiple drug hypersensitivity (MDH) has been defined as a hypersensitivity to two or more chemically unrelated drugs.

Objectives
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call